Genome-Wide Association Study Identifies Pharmacogenomic Variants Associated With Metformin Glycemic Response in African American Patients With Type 2 Diabetes
Baojun Wu(Huazhong Agricultural University), L. Keoki Williams(Henry Ford Health System), Whitney Cabral(Henry Ford Health System), Shujie Xiao(Wayne State University), David E. Lanfear(Henry Ford Health System), Samantha Hochstadt(Henry Ford Health System), Fei Xu(Kaiser Permanente), Kathleen M. Giacomini(University of California, San Francisco), Sneha Sridhar(Kaiser Permanente), Monique M. Hedderson(Kaiser Permanente), Mao Yang(Henry Ford Health System), Sook Wah Yee(Pfizer (United States))
Cited by 14
Related Papers
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
|Journal of Clinical Investigation|2007|951
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone
|Diabetes Care|2011|620
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction
|Circulation|2019|427
Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects
|Journal of Clinical Oncology|2009|352